8-KFiled Jul 28, 8:00 PM ET

Pulmonx Reports Q2 2026 Financial Results

$LUNG · Pulmonx Corp

Research Summary

AI-generated summary of this SEC filing

Updated

Pulmonx Reports Q2 2026 Financial Results

What Happened

  • Pulmonx Corporation announced its financial results for the second fiscal quarter ended June 30, 2026 via a press release dated July 29, 2026. The company furnished the press release on Form 8-K under Item 2.02 (Results of Operations and Financial Condition). The press release is attached to the filing as Exhibit 99.1.

Key Details

  • Filing date: July 29, 2026 (Form 8-K).
  • Reporting period: Second fiscal quarter ended June 30, 2026.
  • Exhibit: Press release titled “Pulmonx Reports Second Quarter 2026 Financial Results” included as Exhibit 99.1.
  • Administrative: Form 8-K signed by Derrick Sung, Ph.D., Chief Operating Officer and Chief Financial Officer; Exhibit 104 (Inline XBRL cover page) included.

Why It Matters

  • This 8-K notifies investors that Pulmonx has published its latest quarterly results; the press release will contain the specific earnings, revenue, cash flow, and any company commentary or guidance that can affect the stock. Investors should review the attached press release (Exhibit 99.1) for the actual financial figures and any operational or forward-looking statements before making decisions.